PF-Atlas › Clinical Trials › NCT07225296

A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNS-3545 in Healthy Participants

GNS-3545 · Phase 1

Registry ID

NCT07225296

Phase

Phase 1

Status

Recruiting

Drug / intervention

GNS-3545

Sponsor

Genosco Inc.

Start

2025-11-12

Enrollment

Locations

About this trial

This is a randomized, double-blind, placebo-controlled Phase 1 study of SAD (Part 1) and MAD (Part 2) of orally administered GNS-3545 in healthy adult subjects. The food effect will be assessed in one cohort in Part 1.

View NCT07225296 on ClinicalTrials.gov →

Explore related

All GNS-3545 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT07225296 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.